During the past decade, Ondokuz Mayis University School of Medicine; Neurology conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 3 clinical trials were completed, i.e. on average, 42.9% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 3 clinical trials were completed. i.e. 75% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ondokuz Mayis University School of Medicine; Neurology" #1 collaborator was "Chugai Pharmaceutical Co." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Ondokuz Mayis University School of Medicine; Neurology" are "Alzheimer's Disease" (3 trials), "Multiple Sclerosis" (2 trials), "Alzheimer Disease" (1 trials), "NMOSD" (1 trials) and "Neuromyelitis Optica Spectrum Disorder" (1 trials). Many other conditions were trialed in "Ondokuz Mayis University School of Medicine; Neurology" in a lesser frequency.

Most popular intervention types in "Ondokuz Mayis University School of Medicine; Neurology" are "Drug" (8 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Gantenerumab" (3 trials), "Ocrelizumab" (2 trials), "Antihistamine" (1 trials) and "Crenezumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ondokuz Mayis University School of Medicine; Neurology" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Ondokuz Mayis University School of Medicine; Neurology". undefined are not yet recruiting, 4 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Ondokuz Mayis University School of Medicine; Neurology, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Ondokuz Mayis University School of Medicine; Neurology, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".